Login

Leon Benjamin, President and CEO of the Glimpse Group, was warmly welcomed at Nasdaq's listing ceremony. 00:10:00

Share On Facebook Share On Twitter

Lyron L Bentovim is Pres/CEO/Co-Founder at Glimpse Group Inc

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Orsu Metals Corporation Presentation
00:10:00
500 Global has backed over 5,000 founders representing more than 2,600 companies operating in 80 countries|Vishal Harnal,Global Managing Partner,500 Global
00:10:00
Managing Derector Eric Yong , Crest Builder Holdings Berhad
00:10:00
C4XD aims to efficiently deliver world leading immunoinflammatory medicines|Clive Dix,CEO,C4X Discovery Holdings
00:10:00
Michael Klein Discusses Trees Corp.'s Strategy for Emerging Cannabis Segments | Michael Klein , CEO, Trees Corporation.
00:10:00
A Leading Global Asset Manager Specializing in the Public & Private Credit Markets|Bruce Richards,CEO, Chairman, & Founder,Marathon
00:10:00
Empowering Women in Finance: Katherine Jollon Colsher's Vision for Diversity | Katherine Jollon Colsher, CEO, Girls Who Invest
00:10:00
Blue Sky Uranium's Amarillo Grande Project: Expanding Argentina's Uranium Potential
00:10:00
"Empowering CEO/Advisors: The Impact of Dynasty Financial Partners' Collaboration with MIT Sloan"
00:10:00
Entrevista com Salesio Nuhs, CEO da Taurus, em um episódio de "Entre Reis & CEOs", discutindo análise fundamentalista da ENGIE Brasil Energia S/A (EGIE3).
00:10:00
Navigating Complex Investment Portfolios with Cynthia Kett | Financial Advisor
00:10:00
30 Years of Trust: Beyond Investing, Building Relationships

© 2026 Nehu